Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2025-10-02 00:00:00 ET · period of report 2025-09-30 · accession 0001727794-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-02 | 2025-09-30 | YARW | Domzalski David | Pres AND CEO, Dir | F - Tax | $0.34 | -12.7K | 428.9K | -3% | -$4,310 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-30 | F | D | 12,676 | $0.34 | 428,892 | D | — | — |